A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Conditions
Solid Tumor · Advanced Solid Tumor · Solid Tumor, Adult · Metastatic Tumor · Ovarian Cancer · Ovarian Neoplasms · Ovarian Carcinoma · Metastatic Ovarian Carcinoma · Endometrial Neoplasms · Endometrial Diseases · Metastatic Endometrial Cancer · Triple Negative Breast Cancer · Metastatic Endometrial Carcinoma · Advanced Endometrial Carcinoma · Advanced Ovarian Carcinoma · Gastric Cancer · Advanced Gastric Carcinoma · Metastatic Gastric Cancer · Metastatic Gastric Carcinoma · Small Cell Lung Cancer · Small Cell Lung Carcinoma · Triple Negative Breast Neoplasms · Platinum-resistant Ovarian Cancer · Platinum-refractory Ovarian Carcinoma · CCNE1 Amplification · Hormone Receptor Negative Breast Carcinoma · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · Progesterone-receptor-positive Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Arkansas Medical School, Little Rock, Arkansas, United States
Contact: Principal Investigator (Michael Birrer, MD)University of California - Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Gottfried Konecny, MD)UCSF, San Francisco, California, United States
SCRI at HealthOne, Denver, Colorado, United States
Contact: Principal Investigator (Gerald Falchook, MD)Florida Cancer Specialists & Research Institute, Lake Mary, Florida, United States
AdventHealth Cancer Institute, Orlando, Florida, United States
Contact: Study coordinator (Advent Health Oncology Research) · CFD.ResearchOncology@AdventHealth.com · 407-303-2090Contact: Principal Investigator (Guru Sonpavde, MD)Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Study coordinator (Winship Referrals) · winship.referrals@emoryhealthcare.org · 404-778-1900Contact: Principal Investigator (Jennifer Scalici, MD)Augusta University, Augusta, Georgia, United States
Contact: Principal Investigator (Sharad Ghamande, MD)University of Kansas, Fairway, Kansas, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Elizabeth LEE, MD)John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey, United States
Contact: Study coordinator (Oncology Clinical Research Referral Office) · OncologyResearchReferral@hmhn.org · 551-996-1777Contact: Principal Investigator (Martin Gutierrez, MD)Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Ida Micaily, MD)UPMC, Pittsburgh, Pennsylvania, United States
Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States
Contact: Principal Investigator (Denise Yardley, MD)NEXT Oncology, Austin, Texas, United States
Contact: Principal Investigator (Sheena Sahota, MD)UT Southwestern, Dallas, Texas, United States
Contact: Principal Investigator (David Miller, MD)Intermountain Health, Salt Lake City, Utah, United States
Contact: Principal Investigator (Caroline Nebhan, MD)University of Virginia, Charlottesville, Virginia, United States
Contact: Principal Investigator (Linda Duska, MD)NEXT Virginia, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira, MD)